Unichem Laboratories Limited (BOM:506690)
376.70
-7.75 (-2.02%)
At close: Jan 21, 2026
Unichem Laboratories Revenue
Unichem Laboratories had revenue of 5.79B INR in the quarter ending September 30, 2025, with 25.27% growth. This brings the company's revenue in the last twelve months to 22.26B, up 25.42% year-over-year. In the fiscal year ending March 31, 2025, Unichem Laboratories had annual revenue of 21.11B with 18.25% growth.
Revenue (ttm)
22.26B
Revenue Growth
+25.42%
P/S Ratio
1.18
Revenue / Employee
7.08M
Employees
3,142
Market Cap
26.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 21.11B | 3.26B | 18.25% |
| Mar 31, 2024 | 17.85B | 4.42B | 32.92% |
| Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
| Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
| Mar 31, 2021 | 12.35B | 1.31B | 11.91% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FDC Limited | 20.77B |
| Morepen Laboratories | 17.56B |
| Hikal | 16.99B |
| Gufic Biosciences | 8.74B |
| Bliss GVS Pharma | 8.60B |
| TTK Healthcare | 8.25B |
| Syncom Formulations (India) | 5.15B |
| Amrutanjan Health Care | 4.70B |